Devices › Device types
FDA product code LJT · class 2 · General Hospital
Port & catheter, implanted, subcutaneous, intravascular: medical device reports filed with FDA
22,475 reports carry this product code, 1992–2026; 30 brands with a page.
- 22,475
- reports with this product code
- 0.1% of all MAUDE reports
- 4,836
- reports, 12 months to August 2026
- 3,208 in the 12 months before
- 38.6%
- classified as malfunction
- 62.3% across all reports
- 1.8%
- classified as death, as reported
- 0.9% across all reports
Product code LJT is FDA's classification for "Port & catheter, implanted, subcutaneous, intravascular" (general Hospital panel), a class 2 device. 22,475 medical device reports carry this product code, 0.1% of the MAUDE database, from February 1992 to August 2026.
4,836 reports arrived in the 12 months to August 2026, up 51% from 3,208 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (57.7%), malfunction (38.6%) and death (1.8%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| C R Bard Basd -3006260740 | 11,674 | 51.9% |
| Bard Access Systems | 3,120 | 13.9% |
| Angiodynamics | 1,093 | 4.9% |
| Horizon Medical Products | 991 | 4.4% |
| Boston Scientific | 347 | 1.5% |
| Bard | 224 | 1% |
| C R Bard | 159 | 0.7% |
| Arrow Intl | 157 | 0.7% |
| Arrow International | 117 | 0.5% |
| United States Surgical | 92 | 0.4% |
| Medcomp | 79 | 0.4% |
| St Paul | 79 | 0.4% |
| Bard Peripheral Vascular | 63 | 0.3% |
| Smiths Healthcare Manufacturing De C V | 58 | 0.3% |
| C R Bard Basd | 51 | 0.2% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Fracturea broken bone | 5,301 | 23.6% |
| Fluid/blood leak | 2,037 | 9.1% |
| Material separation | 2,018 | 9% |
| Explanted | 1,939 | 8.6% |
| Breakthe device broke | 1,905 | 8.5% |
| Deformation due to compressive stress | 1,281 | 5.7% |
| Migrationthe device moved from where it was placed | 1,269 | 5.6% |
| Migration or expulsion of device | 1,216 | 5.4% |
| Suction problem | 1,017 | 4.5% |
| Obstruction of flow | 824 | 3.7% |
| Difficult to flush | 790 | 3.5% |
| Leak/splashthe device leaked | 749 | 3.3% |
| Replace | 721 | 3.2% |
| Device appears to trigger rejection | 668 | 3% |
| Difficult to removethe device was hard to remove | 655 | 2.9% |
| Naturally worn | 640 | 2.8% |
| Component(s), broken | 507 | 2.3% |
| Implant, removal of | 472 | 2.1% |
| Detachment of device or device componentpart of the device came off | 446 | 2% |
| Detachment of device component | 432 | 1.9% |
Questions about port & catheter, implanted, subcutaneous, intravascular reports
What is product code LJT?
FDA's classification code for "Port & catheter, implanted, subcutaneous, intravascular", class 2, reviewed by the general Hospital panel. Every device report carries the product code of the device involved.
How many reports carry this code?
22,475 reports through August 2026, 4,836 of them in the latest 12 months.
Which brands appear most often?
PowerPort ClearVUE isp Implantable Port, ChronoFlex Single-Lumen, 8F (1,327), PowerPort isp M.R.I. Implantable Port, Groshong Single-Lumen, 8F (1,043), PowerPort M.R.I. Implantable Port, ChronoFlex Single-Lumen, 8F (689), PowerPort isp M.R.I. Implantable Port, ChronoFlex Single-Lumen, 8F (669) and Lifeport Vascular Access System (599). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.